Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-568 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-568 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-08 |
filingDate |
1992-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a37fd0ed3133e4788ee8520ed3f82fdd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c181842ff18a424f39a217ab1aefa76a |
publicationDate |
1993-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-H0597882-A |
titleOfInvention |
Novel substituted azetidinones as anti-inflammatory and anti-modifying agents |
abstract |
(57) [Summary] (Modified) [Objective] To provide a new group of substituted azetidinones that are potent elastase inhibitors and useful anti-inflammatory and anti-modifying agents. [Structure] A compound of the following formula (A) and a pharmaceutically acceptable salt thereof. (One example is shown below) (4S) -3,3-diethyl-1- [(R) -α-n-propyl- (4-methyl) benzylaminocarbonyl] -4- [4- (diethoxyphosphinylmethyl) phenoxy] azetidin-2-one |
priorityDate |
1991-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |